About Index Trending news
Analyze
Pricing
Portola Pharma

Portola Pharma

Work at Portola Pharma? Add yourself to this profile

Portola Pharma

Portola (Nasdaq: PTLA) is a biopharma co. focused on developing life-saving therapeutics in thrombosis and hematology.  Twitter policy on our site
Edit Profile
More info

Elsewhere

Companies in the same industry

Nvigen, Inc. Nvigen, Inc. Podimetrics Podimetrics Achaogen Achaogen ScriptRx ScriptRx Ligand Ligand Catasys® Catasys® Genzum Life Sciences Genzum Life Sciences Catabasis Catabasis TriVascular TriVascular SingularityU SingularityU

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
Latest funding
Venture capital (Series D)
$89,000,000
Temasek Holdings, Eastern Capital
Venture capital (Series C)
$60,100,000
Adage Capital Management, Advanced Technology Ventures, D.E. Shaw & Co., +15
Employees

Team size

50+
Locations
Unknown
Help us complete this profile

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Portola Pharma makes some noise.